OncoTherapy Science (TSE:4564) Buyback Yield %: -28.65 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4564 OncoTherapy Science Inc TSE:4564
50 GF Score
Price 円20.00
GF Value 円16.92
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is OncoTherapy Science Buyback Yield %?

OncoTherapy Science TSE:4564 -4.76% 50 Buyback Yield % is -28.65 as of Jul. 19, 2026. GuruFocus rates TSE:4564 with a GF Score™ of 50/100 and a GF Value™ of 円16.92 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 740 Biotechnology companies, OncoTherapy Science ranks worse than 75.68% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

OncoTherapy Science's current buyback yield was -28.65%.

OncoTherapy Science Buyback Yield % Historical Data

* Premium members only.

The historical data trend for OncoTherapy Science's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Buyback Yield % Chart

OncoTherapy Science Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.03 0.00 -14.79 -15.43 -28.36

OncoTherapy Science Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.79 -11.36 -15.43 -16.46 -28.36

TSE:4564 vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, OncoTherapy Science's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoTherapy Science Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoTherapy Science's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where OncoTherapy Science's Buyback Yield % falls into.


TSE:4564
50GF Score
OncoTherapy Science Inc TSE:4564
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoTherapy Science Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

OncoTherapy Science's Buyback Yield for the fiscal year that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2284.433) / 8056.524
=-28.36%

OncoTherapy Science's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 2284.433) / 8056.524
=-28.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -28.65 mean?
OncoTherapy Science (TSE:4564) has a Buyback Yield % of -28.65 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on OncoTherapy Science and its competitors. According to the industry distribution chart, OncoTherapy Science ranks #560 out of 740 companies in the Biotechnology industry, placing it in the top 75.7%.
Is OncoTherapy Science's Buyback Yield % too high?
OncoTherapy Science's current Buyback Yield % is -28.65. Based on the distribution chart, OncoTherapy Science ranks #560 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OncoTherapy Science has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OncoTherapy Science's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OncoTherapy Science ranks #560 out of 740 companies for Buyback Yield %. This places OncoTherapy Science in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on OncoTherapy Science and its competitors. OncoTherapy Science's current Buyback Yield % is -28.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoTherapy Science stock overvalued right now?
Based on GuruFocus' analysis, OncoTherapy Science (TSE:4564) is currently considered Modestly Overvalued. The stock's GF Value™ is 円16.92, compared to a current price of 円20.00 — trading 18.2% above its estimated fair value. The current Buyback Yield % is -28.65. OncoTherapy Science's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For OncoTherapy Science (TSE:4564), the current Buyback Yield % is -28.65 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OncoTherapy Science (TSE:4564) Overvalued in 2026?

Based on GuruFocus' analysis, OncoTherapy Science stock appears to be overvalued. The current stock price of 円20.00 is trading 18.2% above its estimated GF Value™ of 円16.92. GuruFocus considers OncoTherapy Science to be Modestly Overvalued.

Key valuation signals for TSE:4564:

  • Buyback Yield %: -28.65
  • GF Value™: 円16.92 vs. price of 円20.00 (18.2% above fair value)
  • GF Score™: 50/100 with 1 warning sign

No single metric tells the full story. See the TSE:4564 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OncoTherapy Science Business Description

Other Exchanges 30O:Germany
Address 11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
50GF Score

Get the complete analysis for TSE:4564

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円20.00
Price
円16.92
GF Value